Overview

Oxycodone-naloxone Prolonged Release Tablets in Relieving Opioid-related Constipation

Status:
Completed
Trial end date:
2008-09-01
Target enrollment:
Participant gender:
Summary
The primary objective is to demonstrate that patients taking oxycodone/naloxone prolonged release tablets have improvement in symptoms of constipation compared to subjects taking oxycodone prolonged release tablets alone.
Phase:
Phase 3
Details
Lead Sponsor:
Mundipharma Research GmbH & Co KG
Treatments:
Naloxone
Oxycodone